CancerTreatment | Financial Buzz

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Celsion Corporation (NASDAQ: CLSN) Receives FDA Fast Track Designation for GEN-1

financial buzz02/22/2021

2739

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Celsion Corporation Receives FDA Fast Track Designation for GEN-1” Celsion Corporation (NASDAQ: CLSN) surged 66% in premarket trading...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical Products The Market Buzz

Eli Lilly Beats Earnings Expectations

Rebecca Urena01/29/202101/29/2021

2322

Eli Lilly (NYSE: LLY) surpassed Wall Street Expectations regarding fourth-quarter profit on positive sales of its diabetes and cancer drugs. The American pharmaceutical company reported USD871.2 Million in...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Hoth Therapeutics (NASDAQ: HOTH) Production of HT-001 for Cancer Treatment

financial buzz12/31/2020

16853

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Hoth Therapeutics Skyrockets Amid Production of its HT-001 for Cancer Treatment” Hoth Therapeutics (NASDAQ: HOTH) shot up over...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Curis, Inc. (NASDAQ: CRIS) Surges Upon Positive Leukemia Treatment Trial Results

financial buzz12/08/202012/08/2020

2545

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Curis, Inc. Surges Upon Positive Leukemia Treatment Trial Results” Curis, Inc. (NASDAQ: CRIS) surged over 279% in premarket...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Five Prime Therapeutics (NASDAQ: FPRX) Shares Rise on Positive Cancer Trial Results

financial buzz11/11/2020

5003

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Five Prime Therapeutics Shares Rise on Positive Cancer Trial Results” Five Prime Therapeutics (NASDAQ: FPRX) shot up 321%...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz

Bristol-Myers Set to Acquire MyoKardia for $13 Billion

Rebecca Urena10/05/202010/05/2020

2183

Bristol-Myers Squibb (NYSE: BMY), an American pharmaceutical company, announced Monday it will be acquiring MyoKardia for USD13 Billion in order to strengthen its portfolio of heart disease treatments, as...

Tag: CancerTreatment

“The Buzz” Show: Celsion Corporation (NASDAQ: CLSN) Receives FDA Fast Track Designation for GEN-1

Eli Lilly Beats Earnings Expectations

“The Buzz” Show: Hoth Therapeutics (NASDAQ: HOTH) Production of HT-001 for Cancer Treatment

“The Buzz” Show: Curis, Inc. (NASDAQ: CRIS) Surges Upon Positive Leukemia Treatment Trial Results

“The Buzz” Show: Five Prime Therapeutics (NASDAQ: FPRX) Shares Rise on Positive Cancer Trial Results

Bristol-Myers Set to Acquire MyoKardia for $13 Billion

ABOUT US

Tweets